CC
FLGT icon

Corton Capital’s Fulgent Genetics FLGT Stock Holding History

Corton Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,322
Closed -$268K – 467
2024
Q3 		$268K Buy
+12,322
New +$276K 0.13% 235
2024
Q1 		– Sell
-9,741
Closed -$282K – 563
2023
Q4 		$282K Buy
+9,741
New +$261K 0.09% 341
2022
Q2 		– Sell
-3,378
Closed -$211K – 400
2022
Q1 		$211K Buy
+3,378
New +$222K 0.09% 347

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Corton Capital's FLGT Position: Q4 2024 in Review

Corton Capital sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 12,322 shares — an estimated $268K sold.

Corton Capital first reported a position in FLGT in Q1 2022 and held it in 3 quarters. The position peaked at $282K in Q4 2023. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Corton Capital reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 12,322 Fulgent Genetics shares in Q4 2024, an estimated $268K.
  • Corton Capital first reported a position in Fulgent Genetics in Q1 2022 and held it in 3 quarters.
  • Corton Capital's Fulgent Genetics position peaked at $282K in Q4 2023.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.